FindTrial
Sign In

The usefulness of DDAVP test and GHRP-2 test in patients with Cushing's disease

The usefulness of DDAVP test and GHRP-2 test in patients with Cushing's disease - The usefulness of DDAVP test and GHRP-2 test in patients with Cushing's disease

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000018891
Enrollment
15
Registered
2015-10-01
Start date
2015-10-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cushing&#39

Interventions

administration of DDAVP or GHRP-2

Sponsors

Department of Endocrinology and Metabolism, Hirosaki University Graduate School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: We invited patients with Cushing's disease.

Exclusion criteria

Exclusion criteria: Allergy to DDAVP or GHRP-2.

Design outcomes

Primary

MeasureTime frame
Serum ACTH and cortisol after administration of DDAVP or GHRP-2—

Countries

Japan

Contacts

Public ContactKazunori Kageyama

Hirosaki University Graduate School of Medicine Department of Endocrinology and Metabolism

kkageyama@hkg.odn.ne.jp0172-39-5062

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026